{"entity":{"id":"nct06977737","kind":"trial","name":"A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours","aka":[],"tldr":"A phase 1/2 trial of ATTR-01 in advanced solid tumours, run by Accession Therapeutics Limited, now recruiting.","summary":"A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours is a phase 1/2 interventional study registered as NCT06977737 by Accession Therapeutics Limited, with 72 participants planned, started 2025-03-21 and due to reach its primary completion in 2029-12-31. Interventions recorded: ATTR-01.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06977737","url":"https://clinicaltrials.gov/study/NCT06977737"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06977737","phase":"1/2","setting":"A Phase 1-2 Master Protocol to Study Intravenous ATTR-01 in Adult Participants With Select Epithelial Solid Tumours Under Multiple Sub-protocols","sponsor":"Accession Therapeutics Limited","enrolled":72,"outcomes":[]},"route":"/trials/nct06977737/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}